Related Experiment Video
Updated: Jan 30, 2026

An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells
Published on: August 15, 2012
HIV-exposed-uninfected infants have increased inflammation and monocyte activation
Sahera Dirajlal-Fargo1,2,3, Marisa M Mussi-Pinhata4, Adriana Weinberg5
1University Hospitals Cleveland Medical Center.
Insights
HIV-exposed-uninfected infants show heightened inflammation and monocyte activation at birth, persisting to six months. This inflammation may contribute to increased illness and impaired growth in these infants.
Area of Science:
- Immunology
- Pediatrics
- Infectious Diseases
Background:
- HIV-exposed-uninfected (HEU) infants experience higher rates of infectious illness and mortality.
- Limited understanding exists regarding inflammation and monocyte activation levels in HEU infants.
Purpose of the Study:
- To investigate and compare levels of inflammation and monocyte activation markers in HEU infants versus HIV-unexposed infants.
- To determine the persistence of these markers from birth to six months of age.
Main Methods:
- Plasma samples from 86 HEU and 88 HIV-unexposed mother-infant pairs were analyzed at birth and 6 months.
- Assayed inflammatory markers included IL-6, sTNF-RI, sTNF-RII, sCD14, sCD163, IP-10, VCAM, oxLDL, D-dimer, and hs-CRP.
- Maternal HIV-RNA levels and infant outcomes (gestational age, weight, height) were recorded.
Main Results:
- HEU infants exhibited higher inflammatory markers at birth, with soluble TNFα receptor I (sTNF-RI) and IL-6 persisting at 6 months.
- HEU infants had lower mean gestational age and birth weight compared to controls.
- Elevated hs-CRP and IP-10 at birth correlated with lower infant weight at birth and 6 months.
Conclusions:
- HEU infants present with heightened inflammation and monocyte activation at birth, which can persist to 6 months.
- This inflammation is not directly linked to the mother's inflammatory status.
- Inflammation may be a contributing factor to increased infectious morbidity and poor growth observed in HEU infants.
Background:
HIV-exposed-uninfected (HEU) infants have increased infectious morbidity and mortality; little is known about their levels of inflammation and monocyte activation.
Methods:
Plasma samples obtained at birth and 6 months from 86 HEU mother-infant pairs enrolled in the National Institute of Child Health and Human Development cohorts in Brazil were compared with 88 HIV-unexposed mother-infant pairs. HIV-infected mothers received antiretroviral therapy during pregnancy, their infants received zidovudine prophylaxis and were not breastfed. IL-6, soluble TNFα receptor I (sTNF-RI) and II, soluble CD14, soluble CD163, IFN-γ-induced protein 10 (IP-10), vascular cell adhesion molecule, oxidized LDL, D-dimer and high-sensitivity C-reactive protein were assayed by ELISA at birth and at 6 months. sTNF-RI and IL-6 were considered coprimary endpoints.
Results:
Among HIV-infected mothers, 79% had HIV-RNA less than 400 copies/ml prior to delivery. Compared with HIV-unexposed, HEU infants had a lower mean gestational age (38.7 vs. 39.3 weeks) and weight (3.1 vs. 3.3 kg); and reached lower weight (5.9 vs. 8.5 kg) and height (53.6 vs. 68.8 cm) at 6 months. With the exception of vascular cell adhesion molecule, inflammatory markers were generally higher (P ≤ 0.005) in HEU at birth, but at 6 months only sTNF-RI and IL-6 remained higher. For HEU pairs, only IP-10 was associated with maternal levels at birth (P < 0.001). In HEU, elevated levels of high-sensitivity C-reactive protein and IP-10 at birth were associated with lower weight at birth (P = 0.04) and at 6 months (P = 0.04).
Conclusion:
HIV-exposed infants have heightened inflammation and monocyte activation at birth, which for some markers persisted to 6 months of life and was not related to maternal inflammatory status. Inflammation may contribute to the increased HEU infectious morbidity and poor growth.
Related Concept Videos
Inflammation
Increasing Function
Increased Body Temperature
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Drug Dosing: Infants and Children
Secondary Active Transport

